Decoding the human protein interactome for safer, more targeted therapies.
We envision highly effective medicines free from side effects.
95% of approved medicines target proteins as isolated entities, bluntly turning them on or off.
This modulates protein function globally, across pathogenic and healthy cellular pathways. It’s why essentially all medicines come with side effects.
We target protein interactions.
By targeting protein-protein interactions (PPIs), we aim to modulate only the pathogenic pathway, leaving healthy functions intact.
Our platform is purpose-built for high-quality empirical PPI data generation.
In cellulo detection: Quantify PPIs directly in cells via diverse detection modes, surfacing highly transient interactions with rich biological context.
High signal:noise: Large internal controls minimize false positives and negatives.
Exceptional data quality: Several fold higher PPI detection sensitivity than any other in cellulo PPI detection technology, without sacrificing throughput.